Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 8,279 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Effects of Chemotherapy, Aging, Frailty
Interventions: Geriatric Assessments and Frailty Indices; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Adult, Healthy Participants
Interventions: RSVpreF, Placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 60 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Scottsdale, Arizona • Lake Forest, California • Riverside, California + 11 more

Conditions: Rheumatic Diseases, Lupus Erythematosus, Systemic, Lupus Vasculitis, Central Nervous System, Arthritis, Spondylarthritis, Ankylosing Spondylarthritis, Rheumatoid Arthritis, Sjogren's Syndrome
Interventions: Bedside quantitative sensory testing; Device
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 9 Years to 85 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Macular Degeneration, Age-related Macular Degeneration
Interventions: Pazopanib eye drops and Allergen Refresh Plus eye drops; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 30 Years to 55 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 2
States / cities: Fargo, North Dakota • Austin, Texas

Conditions: Fruit and Vegetable Consumption, Cooking Frequency
Interventions: Nutrition and hands on cooking classes for parents and their children, Produce allocations; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Geographic Atrophy, Age Related Macular Degeneration, AMD, Atrophy, Geographic
Interventions: ALK-001 oral capsule, Placebo oral capsule; Drug
Lead sponsor: Alkeus Pharmaceuticals, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 24
States / cities: Phoenix, Arizona • Beverly Hills, California • Lakewood, Colorado + 20 more

Conditions: Traumatic Brain Injury
Interventions: Sildenafil Citrate 50Mg Tab, functional Near-infrared Spectroscopy (fNIRS), Carbon Dioxide (CO2) 5%, Neuropsychological Assessments, Gadolinium contrast infusion, Blood sample collection for research purposes, Structural brain Magnetic Resonance Imaging (MRI; Drug · Device · Other + 1 more
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Complement Mediated Diseases
Interventions: AMY-101; Drug
Lead sponsor: Amyndas Pharmaceuticals S.A.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Preventive Screening, Prostate Cancer, Osteoporosis, Colorectal Cancer
Interventions: Quantitative Information Sheet, Qualitative Information Sheet, Narrative Information Sheet, Framed Information Sheet; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 85 Years
Enrollment: 775 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Perennial Allergic Rhinitis
Interventions: Placebo Nasal Aerosol, Prednisone capsules, Placebo Prednisone Capsules, Beclomethasone dipropionate; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 12 Years to 45 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 3
States / cities: North Dartmouth, Massachusetts • New Braunfels, Texas • San Antonio, Texas

Conditions: Acute Myelogenous Leukemia
Interventions: Cytarabine, Idarubicin, Alisertib; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Erythropoietic Protoporphyria
Interventions: Colestipol; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 22 Years to 60 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Activity, Motor, Sleep, Delirium
Interventions: Wireless Wearable Device; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Retinal Disease, Corneal Disease, Diabetic Retinopathy, Uveitis, Age-Related Macular Degeneration
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: Not listed
Enrollment: 3,833 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer, Ovarian Cancer
Interventions: Telephone Counseling & Navigation (TCN), Mailed Targeted Print (TP), Usual Care (UC); Behavioral · Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years and older · Female only
Enrollment: 668 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Dry Age Related Macular Degeneration.
Interventions: Retinal transplantation instrument, Fetal tissue.; Device
Lead sponsor: Radtke, Norman D., M.D.; Individual
Eligibility: 55 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Carcinoma, Renal Cell
Interventions: Autologous alpha-DC1/TBVA vaccine, Cabozantinib; Biological · Drug
Lead sponsor: Jodi Maranchie; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Influenza
Interventions: VAX161 [STF2.HA5 H5N1]; Biological
Lead sponsor: VaxInnate Corporation; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Miami, Florida • Lenexa, Kansas

Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas, Oligodendroglioma, Diffuse Intrinsic Brainstem Glioma, Diffuse Intrinsic Pontine Glioma, DIPG Brain Tumor, H3 K27M
Interventions: SIACI of cetuximab and bevacizumab; Drug
Lead sponsor: University of Miami; Other
Eligibility: 1 Year to 21 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Chikungunya Virus
Interventions: CHIKV VLP vaccine, Placebo; Biological
Lead sponsor: Bavarian Nordic; Industry
Eligibility: 1 Year to 11 Years
Enrollment: 720 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 8
States / cities: Fountain Valley, California • Washington D.C., District of Columbia • Miami, Florida + 4 more

Conditions: Blood Pressure Measurement
Interventions: Blood Pressure Measurement; Other
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 3 Years to 85 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Neovascular Age-related Macular Degeneration, Macular Degeneration
Interventions: No Intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV, PrEP, PrEP Uptake, HIV Prevention
Interventions: PrOTECT AL Implementation Strategy; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Respiratory Syncytial Virus Infections
Interventions: RSV MAT; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 49 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Missoula, Montana • Norfolk, Nebraska

Search by objective public record fields.

Aging and Frailty Study

A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults

Pain Phenotyping of Rheumatic Diseases - An Observational Study

A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.

Market to MyPlate: Investigating the Impact of a Nutrition and Hands-On Cooking Intervention

Phase 2/3 Study of ALK-001 in Geographic Atrophy

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Understanding and Discouraging Overuse of Potentially Harmful Screening Tests

Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

Alisertib for Acute Myeloid Leukemia

Sorbent Therapy of the Cutaneous Porphyrias

Quantifying Activity Using Wireless Wearable Technology

Tissue Studies of Human Eye Diseases

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.

Autologous Dendritic Cell Vaccine in Kidney Cancer

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study

Photodynamic Therapy for PDA in NV AMD

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy